A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Voriconazole(200mg/Vial) After Intravenous Infusion of 200mg Voriconazole in Healthy Volunteers Under Fasting Conditions.
Latest Information Update: 21 Sep 2020
At a glance
- Drugs Voriconazole (Primary)
- Indications Candidiasis; Fusariosis; Invasive bronchopulmonary aspergillosis; Mycoses
- Focus Pharmacokinetics
- Sponsors Yung Shin Pharmaceutical
- 21 Sep 2020 New trial record